NRC
National Research Corp
$
15.140
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
15.430
Open
15.200
VWAP
15.22
Vol
81.58K
Mkt Cap
348.26M
Low
15.090
Amount
1.24M
EV/EBITDA(TTM)
11.97
Total Shares
23.88M
EV
423.94M
EV/OCF(TTM)
19.90
P/S(TTM)
2.50
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2019Q4
33.10M
+8.03%
0.300
0%
Estimates Revision
Stock Price
Go Up
+9.31%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for National Research Corp (NRC.O) is 13.02, compared to its 5-year average forward P/E of 32.14. For a more detailed relative valuation and DCF analysis to assess National Research Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
32.14
Current PE
13.02
Overvalued PE
42.47
Undervalued PE
21.82
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Undervalued
5Y Average EV/EBITDA
21.14
Current EV/EBITDA
9.39
Overvalued EV/EBITDA
27.77
Undervalued EV/EBITDA
14.52
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
7.14
Current PS
2.62
Overvalued PS
9.56
Undervalued PS
4.72
Financials
Annual
Quarterly
FY2025Q2
YoY :
-2.81%
34.04M
Total Revenue
FY2025Q2
YoY :
-82.09%
1.59M
Operating Profit
FY2025Q2
YoY :
-101.72%
-106.00K
Net Income after Tax
FY2025Q2
YoY :
-100.00%
0.00
EPS - Diluted
FY2025Q2
YoY :
-373.50%
-4.15M
Free Cash Flow
FY2025Q2
YoY :
+7.90%
61.88
Gross Profit Margin - %
FY2025Q2
YoY :
-57.41%
6.61
FCF Margin - %
FY2025Q2
YoY :
-101.76%
-0.31
Net Margin - %
FY2025Q2
YoY :
-34.95%
22.02
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
1
10.0K
USD
Months
3-6
1
34.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
1
10.0K
USD
Months
3-6
1
34.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
NRC News & Events
Events Timeline
2025-07-28 (ET)
2025-07-28
17:02:27
National Research Corporation reports Q2 EPS (1c) vs. 26c last year
2025-03-04 (ET)
2025-03-04
16:06:35
National Research Corporation names Trent Green as new CEO
2025-01-07 (ET)
2025-01-07
11:02:11
NRC Health enters partnership with Renown Health
Sign Up For More Events
Sign Up For More Events
News
2.0
04-10NewsfilterA New Era of Trust: NRC Health's 2025 Experience Perspective Report Reveals Insights to Elevate the Healthcare Experience
2.0
04-10Yahoo FinanceA New Era of Trust: NRC Health’s 2025 Experience Perspective Report Reveals Insights to Elevate the Healthcare Experience
8.0
03-24NewsfilterNational Research Corporation Declares Quarterly Dividend
Sign Up For More News
People Also Watch
ASPI
ASP Isotopes Inc
9.855
USD
+5.74%
BWMX
Betterware de Mexico SAPI de CV
12.840
USD
-3.96%
LE
Lands End Inc
12.910
USD
-0.39%
QSI
Quantum-Si Inc
1.190
USD
-6.30%
XPER
Xperi Inc
6.020
USD
-1.63%
DIN
Dine Brands Global Inc
20.830
USD
-1.09%
SGU
Star Group LP
11.540
USD
-1.37%
CELC
Celcuity Inc
46.090
USD
+0.46%
DHIL
Diamond Hill Investment Group Inc
142.980
USD
+0.40%
CDXS
Codexis Inc
2.940
USD
+6.14%
FAQ
What is National Research Corp (NRC) stock price today?
The current price of NRC is 15.14 USD — it has increased 0.26 % in the last trading day.
What is National Research Corp (NRC)'s business?
What is the price predicton of NRC Stock?
What is National Research Corp (NRC)'s revenue for the last quarter?
What is National Research Corp (NRC)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for National Research Corp (NRC)'s fundamentals?
How many employees does National Research Corp (NRC). have?